Bloomberg Intelligence cover image

Kimberly-Clark to Buy Tylenol Maker Kenvue for $40 Billion

Bloomberg Intelligence

00:00

Market Reaction and Synergy Skepticism

Scarlet asks why Kimberly-Clark shares plunged and Diana explains skepticism about revenue and cost synergies.

Play episode from 02:49
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app